Currently out of the existing stock ratings of Ryan Blicker, 7 are a BUY (100%).

Ryan Blicker

Work Performance Price Targets & Ratings Chart

Analyst Ryan Blicker, currently employed carries an average stock price target met ratio of 100% that have a potential upside of 11.66% achieved within 66 days. Previously, Ryan Blicker worked at TD COWEN.

Ryan Blicker’s has documented 16 price targets and ratings displayed on 2 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on DXCM, DexCom at 07-Jul-2020.

Wall Street Analyst Ryan Blicker

Analyst best performing recommendations are on DXCM (DEXCOM).
The best stock recommendation documented was for DXCM (DEXCOM) at 4/1/2020. The price target of $75 was fulfilled within 15 days with a profit of $11.3 (17.74%) receiving and performance score of 11.83.

Average potential price target upside

DXCM DexCom TNDM Tandem Diabetes Care

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$105

$31.56 (42.97%)

$115

5 days ago
(25-Oct-2024)

19/23 (82.61%)

$31.56 (42.97%)

84

Buy

$86

$12.56 (17.10%)

$150

5 days ago
(25-Oct-2024)

1/3 (33.33%)

$12.56 (17.10%)

105

Buy

$99

$25.56 (34.80%)

$160

5 days ago
(25-Oct-2024)

17/23 (73.91%)

$25.56 (34.80%)

139

Buy

$90

$16.56 (22.55%)

$80

5 days ago
(25-Oct-2024)

8/11 (72.73%)

$16.56 (22.55%)

82

Hold

$85

$11.56 (15.74%)

$75

5 days ago
(25-Oct-2024)

8/10 (80%)

$11.56 (15.74%)

72

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Ryan Blicker?

On 2017

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?